loader2
Partner With Us NRI

Company details

1,395.85
1,440.00
1,377.55
3,579.00
6M Return -58.27%
1Y Return -49.41%
Mkt Cap.(Cr) 7,344.46
Volume 6,436
Div Yield 0.57%
OI
-
OI Chg %
-
Volume 6,436

Open Free Demat Account Online with ICICIDIRECT

SWOT

  • swot

  • technicals

  • deals

  • shareholding


EMA SMA

Delivery and volume

Financials

  • Profit and loss statement

  • Balance sheet

  • Quarterly Result

  • Ratio

Sales(Cr.)

Operating Profit(Cr.)

Profit after Tax(Cr.)

Equity

Reserves and Surplus

Debt

Sales

Operating Profit

Profit after tax

PE

Debt/Equity

P BV

INSIDER & INSTITUIONAL ACTIVITY

Equity Capital: 706.60 Cr FV: 2.00
Period MF Net Purchase / (sold) FII Net
LAST 1M 20,712.90 -49,208.14
LAST 3M 72,514.10 -86,871.53
LAST 6M 139,386.11 -217,992.74
LAST 12M 232,044.22 -250,830.89

Information

  • About Company
  • Company Info
  • Listing Info
35.56
49.79%
173.1704
35.83%
29.81%

No Data Found

AGM Date (Month) : Aug
Face Value Equity Shares : 2
Market Lot Equity Shares : 1
BSE Code : 542650
NSE Code : METROPOLIS
Book Closure Date (Month) :
BSE Group : A
ISIN : INE112L01020

ICICIdirect Metropolis Healthcare Ltd FAQ

You can buy Metropolis Healthcare Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Metropolis Healthcare Ltd Share.
Company share prices and volatile and keep changing according to the market conditions. As of Jul 01, 2022 04:01 PM the closing price of Metropolis Healthcare Ltd was ₹ 1,435.25.
Market capitalization or market cap is determined by multiplying the current market price of a company’s shares with the total number of shares outstanding. As of Jul 01, 2022 04:01 PM, the market cap of Metropolis Healthcare Ltd stood at ₹ 7,344.46.
The latest PE ratio of Metropolis Healthcare Ltd as of Jul 01, 2022 04:01 PM is 35.56
The latest PB ratio of Metropolis Healthcare Ltd as of Jul 01, 2022 04:01 PM is 0.12
The 52-week high of Metropolis Healthcare Ltd is ₹ 3,579.00 while the 52-week low is ₹ 1,377.55 .

Thank you for subscribing to Equity/ Equity Research/MF/FnO Newsletter. You will hear from us shortly.

for your vote

CLOSE